Avita Medical Inc (RCEL)

R&D Expense Growth

-9.79%

Quarterly · Period ending:

RCEL logo

RCEL R&D Expense Growth

Latest reported-9.79%
RCEL Quarterly R&D Growth (QoQ) (0.00% → -9.79%)
High-resolution chart · PNG

RCEL r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Avita Medical Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-9.7886%
-1.0721%
51.8143%
-26.754%
-18.571%
29.567%
-10.6485%
11.0702%
-5.9107%
-23.2225%
53.9599%
-13.4358%
10.6847%
35.7206%
-11.0555%
24.1909%
-15.4972%
-13.7685%
23.9079%
-14.7458%
-3.2855%
22.2553%
-0.3853%
83.8692%
-55.3371%
25.1613%
-8.7488%
61.7594%
10.9502%
-37.8963%
-8.8305%
845.2054%
-90.0836%
47.2341%
1.5605%
34.0842%
0.3983%
48.8809%
0.2027%
31.9761%
-0.5549%
23.9068%
-0.0075%
-45.8369%
0.8711%
214.9097%
-4.7505%
-40.5227%
0.1713%
209.9142%
-9.8052%
-60.197%
-0.7037%
22.5293%
4.7504%
52.6668%
-64.0988%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.